T1	intervention 31 42	weight loss
T2	control 50 60	usual care
T3	eligibility 608 631	breast cancer survivors
T4	total-participants 633 636	151
T5	intervention-participants 765 767	93
T6	control-participants 791 793	58
T8	total-participants 1202 1205	125
T9	age 1231 1243	58 ± 8 years
T10	ethinicity 1321 1339	non-Hispanic white
T11	outcome 1433 1453	telomere lengthening
T12	iv-bin-percent 1430 1432	3%
T13	cv-bin-percent 1466 1468	5%
T14	outcome 1582 1602	telomere lengthening
T15	cv-bin-percent 1615 1617	8%
T16	iv-bin-percent 1579 1581	7%
